Parkinson’s Disease
165 results.
GRAND RAPIDS, Mich. (Dec. 10, 2025) — Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials…
LONDON (Oct. 16, 2025) — The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by…
Here at Van Andel Institute, September marks more than the turn of the season: it signifies the return of our annual Grand Challenges in Parkinson’s…
GRAND RAPIDS, Mich. (Sept. 15, 2025) — The annual Tom Isaacs Award, jointly presented by Cure Parkinson’s and Van Andel Institute (VAI), honors…
Our cells create a lot of waste and, just like us, they need a way to get rid of it.
That’s the job of the…
Alpha-synuclein (α-synuclein) is a protein most known for its involvement in Parkinson’s disease.
We have α-synuclein throughout our tissues, with the highest…
GRAND RAPIDS, Mich. (April 14, 2025) — Van Andel Institute has named renowned physician-scientist
J. Timothy Greenamyre, M.D., Ph.D., as…
GRAND RAPIDS, Mich. (April 14, 2025) — Aging is the most important risk factor for neurodegenerative diseases, including Parkinson’s disease. However, the connection between aging…